| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |